Prognostic value of ctDNA mutation in melanoma: A meta-analysis
Source: MDLinx, May 2021
The selection of the studies was carried out using PubMed, EMBASE, Web of Science, and Cochrane databases to evaluate the prognostic value of the presence or change in circulating tumor DNA (ctDNA) mutations in patients with melanoma. Sixteen studies with a total of 1,781 patients were included.
